. mahoganoid is another coat-color mutation whose pigmentation is very similar to that of Atrn (formerly mahogany) (11) (12) (13) . Both mutations lie in the same epistasis group and suppress obesity caused by ectopic brain expression of Agouti (14) . To investigate whether the gene mutated in mahoganoid carries out a neuronal function similar to that of Atrn, we examined two alleles of mahoganoid that differ in their effects on coat color ( fig. S1 ). Animals carrying the original allele, md, synthesize small amounts of yellow pigment on the flank and the ventrum and do not develop spongy degeneration up to 5 months of age (15, 16 ) . However, animals carrying the md nc allele (originally known as nonagouti curly) develop progressive spongiform changes, first apparent in the hippocampus CA3 region at 2 months of age and later extending to multiple regions of the brain (Fig. 1A and fig.  S1 ). Vacuolation predominates in gray matter and is associated with neuronal loss but preservation of tissue architecture; the cerebral cortex, hippocampus, thalamus, brain stem, caudate-putamen, and cerebellum granule layer are the most consistently affected regions. These pathological features are nearly identical to those of Atrn mice exhibit moderate to severe astrocytosis, the extent of which correlates with the degree of vacuolation and neuronal cell loss (Fig. 1B) . In md nc /md nc mice at 10 months of age, some regions of the deep cortex and lateral thalamus exhibit mild astrocytosis before the formation of microscopically visible vacuoles. Electron microscopy showed that most vacuoles in the gray matter from 6-month-old Atrn mg-3J / Atrn mg-3J animals were membrane bound, not enclosed by myelin sheaths, and appeared to originate from dendrites or astrocytic processes (Fig. 1C) . Membrane debris was often found within primary vacuoles; secondary vacuoles were often distributed along the periphery of the primary vacuolar membrane (17) . These neuropathologic features are characteristic of prion diseases, in which conformational changes in the prion protein (PrP) lead to an accumulation of the protease-resistant PrP isoform, PrP Sc (18, 19 ] from a single gene detected reduced levels of normal-sized transcript and transcripts of aberrant size, and sequence analysis detected an intracisternal A particle (IAP) insertion in intron 11a. For the md nc allele, no transcript was detected by Northern hybridization, and a thymidine to adenine mutation was identified in position 2 of intron 9 (Fig. 2) . Thus, partial loss of function for this gene, which we refer to as Mahogunin, causes a reduction of yellow pigment in the md allele, and complete loss of function causes absence of yellow pigment and neurodegeneration in the md nc allele. Like Atrn, the Mahogunin gene is widely expressed in adult tissues and is closely related to genes in other metazoans (SOM Text, fig. S2 ). There are four mRNA isoforms that contain a central C3HC4 RING domain as the only recognizable protein motif; however, regions flanking the RING domain and the amino-terminal region of the protein are also conserved between vertebrate and invertebrate genomes (figs. S2 and S3).
A number of RING-containing proteins function as E3 ubiquitin ligases (20, 21) and transfer ubiquitin to specific protein substrates to aid in their proteasomal degradation. E3 ubiquitin ligases often exhibit autoubiquitination in vitro whether or not the endogenous target is present. To test whether Mahogunin would catalyze ubiquitin ligation in vitro, we incubated a glutathione-S-transferase (GST) fusion protein with adenosine triphosphate (ATP), E1 (UBA1) and E2 (UBC5) proteins, and FLAG epitope-tagged ubiquitin. After Western blot analysis of the reaction products, the two tested GST-Mahogunin isoforms exhibited a characteristic polyubiquitin ladder (Fig. 3A) . Autoubiquitination was dependent on ATP, E1, E2, and an intact Mahogunin RING domain (Fig. 3A) , with ladder formation proportional to the amounts (0.1 to 0.5 M) of GST-Mahogunin (Fig. 3A and fig. S3 ). In addition, Mahogunin-induced autoubiquitination exhibited specificity for E2; it occurred with UBC5, used frequently in the stress response to unfolded proteins, but not with UBC3, used frequently in cell-cycle transitions (Fig. 3B) . Taken together, these observations establish the E3 ubiquitin ligase activity of Mahogunin and suggest that abnormal protein metabo- We also found occasional vacuoles within neuronal cell bodies in the cerebellum that contained disorganized organelles but relatively intact nuclei (15) . Scale bars are 50 m in (A) and (B) and 1 m in (C) (16) . fig. S4 ), which suggests that proteins that regulate Atrn metabolism are not targets for ubiquitin-dependent proteasomal degradation by Mahogunin. We also tested directly whether PrP was a potential substrate for Mahogunin-mediated ubiquitination and found that recombinant hamster PrP was not ubiquitinated in vitro in the presence of active Mahogunin (fig. S4) .
In addition to similar pigmentary and neurodegeneration phenotypes, Atrn and Mahogunin mRNA are expressed in similar patterns, with the cerebral cortex, hippocampus, cerebellum, and specific midbrain nuclei exhibiting strong expression of both genes ( fig.  S4) . Atrn mg-3J does not affect levels of Mahogunin mRNA, nor does md nc affect levels of Atrn mRNA ( fig. S4) (15) . To further investigate the genetic relationship between Mahogunin and Atrn, we asked whether Atrn cDNA transgenes driven by the ␤-actin (ACTB) or dopachrome tautomerase (Dct) promoters (5) We propose a model in which Atrn normally activates Mahogunin-catalyzed ubiquitination of an as-yet unidentified substrate(s), which then becomes targeted for proteasomal degradation. In Atrn or mahoganoid mutant mice, neuronal accumulation of this substrate(s) leads to progressive vacuolation, astrocytosis, and neuronal cell death (Fig. 3C) . The relationship between prion-induced spongiform encephalopathy and spongy degeneration in mahoganoid mice may be analogous to Parkinson's disease, in which recessive forms of the condition are caused by loss-of-function mutations in the E3 ubiquitin ligase Parkin, whereas dominant forms are caused by gain-of-function mutations in Parkin substrates (22) (23) (24) (25) (26) . Although mature PrP is not ubiquitinated by Mahogunin, other potential substrates are cellular components that regulate PrP metabolism and/or are involved in oxidative damage, because changes in oxidative stress are associated with prion disease (27 ) and have also been described in the zitter rat, another loss-offunction mutation for Atrn (28 
